Centiva Capital LP Purchases New Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

Centiva Capital LP acquired a new stake in Definitive Healthcare Corp. (NASDAQ:DH) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 41,469 shares of the company’s stock, valued at approximately $185,000.

Several other large investors also recently modified their holdings of DH. Massachusetts Financial Services Co. MA lifted its holdings in Definitive Healthcare by 36.8% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock worth $27,058,000 after buying an additional 1,626,813 shares in the last quarter. 272 Capital LP bought a new stake in shares of Definitive Healthcare during the 2nd quarter valued at $3,480,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Definitive Healthcare during the 3rd quarter valued at $512,000. Marshall Wace LLP bought a new stake in shares of Definitive Healthcare during the 2nd quarter valued at $1,535,000. Finally, Millennium Management LLC bought a new stake in shares of Definitive Healthcare during the 2nd quarter valued at $9,283,000. 98.67% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

DH has been the subject of a number of recent analyst reports. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research report on Friday, November 8th. BTIG Research initiated coverage on shares of Definitive Healthcare in a research report on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price objective for the company. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, Definitive Healthcare presently has an average rating of “Hold” and an average price target of $5.81.

Insiders Place Their Bets

In other news, insider William Moschella sold 45,000 shares of the stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the sale, the insider now directly owns 433,830 shares of the company’s stock, valued at $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 14.84% of the company’s stock.

Definitive Healthcare Stock Performance

Shares of NASDAQ:DH opened at $4.50 on Friday. The company has a market cap of $519.85 million, a price-to-earnings ratio of -1.45, a price-to-earnings-growth ratio of 3.44 and a beta of 1.39. The company has a 50-day moving average price of $4.41 and a 200-day moving average price of $4.73. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare Corp. has a 12 month low of $3.19 and a 12 month high of $10.62.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.